Inspiration Healthcare Group recorded first-half revenue of A322 million, the company said on Tuesday, a decline versus the comparable prior period driven by the non-recurrence of certain one-off export contracts that inflated last years numbers.
Despite the headline drop, several underlying lines showed notable expansion. When excluding one-off export contracts from the prior-year comparator, revenues from the companys SLE products rose 38% year-over-year, reflecting sustained demand for its core neonatal intensive care devices.
Airon revenues climbed 40% to A31.6 million. That increase was supported by an initial order placed under a three-year purchasing agreement with a large US healthcare provider, the company said, contributing to Airons stronger performance in the period.
Meanwhile, the MedTech distribution business delivered a 7% increase in revenue year-over-year, adding to the pockets of growth within the group. A0
On outlook, Inspiration Healthcare said it expects to close the full financial year slightly ahead of company-compiled market expectations and highlighted that it enters the second half with a strong orderbook, which management intends to convert into further revenue.
Financial snapshot
- Reported first-half revenue: A322 million.
- SLE product revenue: up 38% year-over-year on a like-for-like basis excluding one-off export contracts.
- Airon revenue: up 40% to A31.6 million, driven by an initial order from a large US healthcare provider under a three-year agreement.
- MedTech distribution revenue: up 7% year-over-year.
The companys statement framed the H1 figures as a mix of a lower headline total, due to non-recurrent export business in the prior year, and continued momentum across its neonatal device range and distribution activities. Managements expectation to finish slightly above its own market compilation and the presence of a robust orderbook form the basis for its second-half outlook.